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INTRODUCTION 1
Age-dependent maturation of the expression or activity of drug metabolizing enzymes (DMEs) 2 in humans is commonly observed (Hines, 2008) . While substantial data exist on the ontogeny 3 of major microsomal DMEs, age-dependent regulation of cytosolic enzymes is not well 4 studied. Alcohol dehydrogenase 1 isoforms (ADH1A, ADH1B and ADH1C) and aldehyde 5 dehydrogenase 1A1 (ALDH1A1) are high-abundant cytosolic proteins in human liver 6 (Edenberg, 2000; Sladek, 2003) , and belong to a family of NAD(P) + -dependent enzymes and 7 primarily involved in the biotransformation of primary alcohols to aldehydes and aldehydes to 8 weak carboxylic acids, respectively (Sladek, 2003) . For example, these enzymes play major 
11
ALDH1A1 is responsible for converting retinaldehyde to retinoic acid, whereas ADH enzymes 12 convert ethanol to acetaldehyde. CP is first converted by multiple cytochrome P450 enzymes
13
to 4-hydroxy-CP which exists in equilibrium with its open ring tautomer, aldophosphamide.
14 Both 4-hydroxy CP and aldophosphamide are irreversibly deactivated by ADHs and ALDH1A1
15
to 4-keto CP and carboxyphosphamide, respectively. The ALDH-catalysed detoxification
16
reaction competes with the activation reaction that converts aldophosphamide to cytotoxic 17 phosphoramide mustard, which is responsible for the anticancer activity (de Jonge et al.,
18
2005). Therefore, these enzymes play a major role in determining the efficacy as well as off-
19
target toxicity of CP.
20
Immature levels of DMEs and transporters are often associated with reduced clearance and
21
an increased risk of toxicity of xenobiotics in children (Hines, 2008) . While midterm fetal levels
22
of hepatic ADH and ALDH are significantly lower relative to adults (Smith et al., 1971 ),
23
ontogenic trajectories of these proteins across the entire age spectrum from new-borns to 24 adults have not been established. Such data are important to predict the effect of age on in
25
vivo clearance of ADHs and ALDH1A1 substrates in children before clinical use. Therefore,
26
we quantified ADH1A, ADH1B, ADH1C and ALDH1A1 in the hepatic cytosolic (HLC) fractions
27
isolated from a bank of tissues using our well-established proteomics methodology (Prasad et 
28
This article has not been copyedited and formatted. The final version may differ from this version. 
24
Adultmax is the maximum average relative protein abundance, Age is the age in years of the 25 subject at the time of sample collection, Age50 is the age in years at which half-maximum
26
This article has not been copyedited and formatted. The final version may differ from this version. 7
RESULTS AND DISCUSSION
9
The dynamic detection range was established for internal standard peptides (Supplementary 10 Table 3S ). There was no saturation of signal at higher points. The lower limit of quantification Figure 1S) . Neonatal levels of ADH1A, ADH1B,
15
ADH1C and ALDH1A1 were 3-, 8-, 146-and 3-fold lower than the adult levels, respectively
16
( Figure 1) . Age50 values, i.e., the age at which protein expression is 50% of maximum 
26
There was no significant effect of gender on ADHs and ALDH1A1 abundance (Supplementary 27 Figure 2S ). While we detected SNPs in ADH1A (rs1826909, rs6811453, rs7684674 and 
15
contrast to a previous study in adults (Smith et al., 1971 ) that reports low to non-detectable
16
ADH1A levels, we have detected ADH1A protein levels in all of our samples, which is likely 
15
The allelic variants ADH1B*2 (rs1229984), ADH1B*3 (rs1229984), and ADH1C*1 are 
26
and only one donor in our liver banks was observed to carry this gene variation.
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